Lumos Pharma(LUMO) - 2023 Q4 - Earnings Call Transcript
Conference Call Participants I will now turn the call over to Lisa Miller, Vice President of Investor Relations. Please go ahead. I will now turn the call over to Rick. Before I begin, I'd like to take a moment to congratulate Dr. Duke Pitukcheewanont on his recent promotion to the role of Chief Medical Officer for Lumos. Dr. Duke's exceptional credentials are widely acknowledged, given his renowned expertise in growth [hormone] (ph) disorders and his current leadership at the Human Growth Foundation among ...